Nuvectis Pharma
NVCT
NVCT
33 hedge funds and large institutions have $20M invested in Nuvectis Pharma in 2025 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 3 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
+2
Holders Change %
+6.45%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
13
Reduced
3
Closed
8
Calls
$1.3M
Puts
$895K
Net Calls
+$406K
Net Calls Change
+$406K
Top Buyers
1 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$2.48M |
2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.39M |
3 |
UBS Group
Zurich,
Switzerland
|
+$1.06M |
4 |
Millennium Management
New York
|
+$893K |
5 |
Geode Capital Management
Boston,
Massachusetts
|
+$548K |